Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) shares rose 47.4% on Saturday . The stock traded as high as C$0.14 and last traded at C$0.14. Approximately 1,312,210 shares traded hands during trading, an increase of 427% from the average daily volume of 249,010 shares. The stock had previously closed at C$0.10.
Voyageur Pharmaceuticals Price Performance
The firm has a market cap of C$19.53 million, a PE ratio of -14.00 and a beta of 0.32. The company has a debt-to-equity ratio of 3.21, a current ratio of 0.17 and a quick ratio of 0.84. The business’s fifty day moving average is C$0.07 and its 200-day moving average is C$0.06.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Featured Articles
- Five stocks we like better than Voyageur Pharmaceuticals
- What Are Dividend Challengers?
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- What does consumer price index measure?
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- High Flyers: 3 Natural Gas Stocks for March 2022
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
